Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3042% above fair value
$278.32−0.93 (-0.33%)
Close on Nov 18, 2026Market cap $64.73BP/E 38.5Yield 0.73%
Cardinal Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cardinal Health
Cardinal Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?